| HS Code | 663135 |
| Product Name | Chloramine-T Veterinary Grade API |
| Active Ingredient | Chloramine-T |
| Chemical Name | N-Chloro-4-methylbenzenesulfonamide sodium salt |
| Synonyms | Chloramine-T, Tosylchloramide sodium, N-Chloro-p-toluenesulfonamide sodium |
| Cas Number | 127-65-1 |
| Einecs Number | 204-854-7 |
| Molecular Formula | C7H7ClNNaO2S |
| Molecular Weight | 227.64 g/mol |
| Grade | Veterinary Grade API |
| Appearance | White to off-white crystalline powder |
| Odor | Faint chlorine-like odor |
| Solubility | Freely soluble in water; soluble in ethanol; practically insoluble in ether and chloroform |
| Ph | 9.0 to 10.5 (5% aqueous solution) |
| Assay | 98.0% to 102.0% (anhydrous basis) |
| Therapeutic Class | Antiseptic / Disinfectant |
| Antimicrobial Spectrum | Bactericidal, virucidal, fungicidal, sporicidal |
| Mechanism Of Action | Oxidative chlorination of microbial proteins and enzymes |
| Available Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Storage Conditions | Store in a cool, dry place, protected from light, in tightly closed containers |
| Shelf Life | 24 to 36 months when stored properly |
| Packaging | Fiber drums, HDPE drums, or as per customer requirement |
| Regulatory Status | Veterinary API |
| Usage | Disinfection and antiseptic applications in veterinary practice |
As an accredited Chloramine-T Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Chloramine-T Veterinary Grade API: 25 kg double-lined fiber drums; pharma-grade sealed containers for tablets, capsules, injections, solutions, powders, granules, premixes. |
| Container Loading (20′ FCL) | Chloramine-T Veterinary Grade API loaded in 20′ FCL, securely palletized/drummed, moisture-protected, for tablets, injections, capsules, powders, granules, premix, solutions. |
| Shipping | Chloramine-T Veterinary Grade API is shipped in sealed, moisture-resistant, properly labeled containers under controlled conditions, away from acids, reducers, and organics. As an oxidizer/hazardous material, it follows IATA/IMDG/ADR rules with SDS, documentation, and secure packaging suitable for tablets, injections, capsules, powders, granules, premix, or solutions. |
| Storage | Store Chloramine-T Veterinary Grade API in tightly closed, original containers in a cool, dry, well-ventilated area, away from direct sunlight, heat, ignition sources, moisture, acids, alkalis, oxidizers, reducing agents, ammonia, and organic matter. Keep separate from food, feed, and drinking water. For tablets, injections, capsules, powders, granules, premixes, or solutions, follow final product labeling and manufacturer stability/safety instructions. |
| Shelf Life | Chloramine-T veterinary grade API: typically 2–3 years for solids; solutions shorter. Store cool, dry, dark, airtight; confirm supplier retest date. |
Chloramine-T veterinary grade API is received as a white crystalline trihydrate with an active chlorine fraction of 23–26% w/w. Before any downstream unit operation, the powder is screened through a 20-mesh inline sifter and stored in sealed high-density polyethylene drums at 20–25°C and relative humidity below 30%. In a large-animal surgical suite, 4.0 g of dry API is dissolved in 1.0 L of freshly distilled water at 20–25°C in a 316L stainless steel jacketed vessel, yielding a 0.4% w/v wound irrigation solution. Dissolution is completed with low-shear propeller agitation at 200–300 rpm for 10 min. The solution is passed through a 0.22 µm polyethersulfone membrane cartridge at a flow rate not exceeding 5 L/min. Terminal steam sterilization is avoided because exposure to 121°C accelerates active chlorine loss and produces p-toluenesulfonamide breakdown products. For intrauterine lavage in postpartum dairy cows, a lower concentration of 0.1% w/v is used, warmed to 37°C, and retained for 3–5 min before gravity drainage. Contact with copper, brass, or cast iron fittings is eliminated from the filling line because transition metals catalyze chloramine-T decomposition. The compounded solution is filled into high-density polyethylene bottles under a laminar-flow cabinet and must be used within 24 h because active chlorine residual declines with hydrolysis and fluorescent light exposure. A 0.5% w/v solution is used for saturating gauze sponges in equine hoof abscess packing; the gauze is applied at the point of care for 15 min. Release of the compounded preparation follows the microbial quality guidance of Ph. Eur. 5.1.4 where sterility is not claimed, although surgical irrigation protocols typically require in-house sterility validation. Published data for wound-healing endpoints under this specific veterinary indication are limited; the solution is not a replacement for debridement, drainage, or systemic antimicrobial therapy.
In flow-through and recirculating tank systems, chloramine-T powder is pre-dissolved in 10 L of pond water per 100 g of API in a high-density polyethylene bucket using a polypropylene stir bar. The resulting stock solution is applied to the aerated biofilter bypass line over 30 min. For bacterial gill disease in salmonids, a dose of 7–15 mg/L is held for 60 min under a partial water exchange of 30–50%. For external protozoan infestations, a higher dose of 20 mg/L is used for 30 min, but only when water temperature is below 16°C and dissolved oxygen is maintained above 7 mg/L. The upper dose is constrained by gill pathology thresholds observed in rainbow trout at temperatures above 18°C; above 20°C the dose is reduced by 20% because oxidant toxicity increases with metabolic rate and gill perfusion. Ultraviolet sterilizers, ozone generators, and protein skimmers are switched off during treatment, and carbon filtration is bypassed. Mechanical filtration remains operational, but heavy organic load consumes available chlorine rapidly; if total organic carbon exceeds 15 mg/L, the initial dose may be depleted within 20 min. Operators measure total chlorine at the drain every 10 min using a DPD photometer at 530 nm following ISO 7393-2; minimum effective residual during treatment is 3 mg/L, and the oxidation-reduction potential is held at 650–750 mV versus Ag/AgCl. At the end of the contact period, 30–50% of the system volume is exchanged over 1 h, and the biofilter is reconnected only after the residual falls below 0.1 mg/L. Repeated dosing every 24–48 h for up to 3 consecutive treatments is the maximum described in regulatory labels; longer sequences suppress feeding and increase plasma cortisol in salmonids. Published data for tropical ornamental species are limited, and extrapolation from salmonid kinetic models is not acceptable for prescription decisions. Chloramine-T use in aquaculture is regulated under EU BPR 528/2012 product-type PT3 where national authorizations exist, and in some jurisdictions it requires veterinary prescription and a slaughter withdrawal period. The process is incompatible with thiosulfate-based dechlorinators during the contact phase because neutralization is immediate.
A 0.3–0.5% w/v chloramine-T solution has been evaluated as a post-milking teat antiseptic in lactating dairy cows, applied using a dip cup within 5 min after cluster removal. The formulated dip includes 10% w/w glycerin as a humectant because the oxidizer removes stratum corneum lipids. The dip solution is prepared fresh at 20–25°C by adding 30–50 g of dry API to 10 L of softened water; pH is adjusted with sodium carbonate to 8.0–8.5. Teat contact time is 60 s, followed by air drying before cow exit. When a 0.5% chloramine-T formulation was evaluated under OECD 404 dermal irritation protocols, erythema scores exceeded 2 in some animals after repeated exposure 3 times daily for 5 days, indicating moderate irritation. This skin effect restricts the practical dip concentration to 0.3% in most herd protocols. Peer-reviewed efficacy data using natural mastitis challenge in commercial dairy herds are limited; the absence of a positive control trial with iodine-based dips prevents a claim of non-inferiority under current mastitis control standards. Chloramine-T is not listed as a first-line teat disinfectant in the International Dairy Federation mastitis prevention table, and its use is generally confined to cleaning teats with visibly contaminated skin. Equipment exposure is limited to polyethylene dip cups and high-density polyethylene mixing vessels; contact with stainless steel is acceptable only under continuous alkaline pH above 8.0 because acidic hydrolysis generates hypochlorous acid and accelerates pitting. Residual disinfectant in the milking parlor wash water must be neutralized with sodium thiosulfate at 0.5 g per 100 L before discharge to biological lagoons. Published data for a specific post-milking field protocol under FDA or EMA mastitis regulatory guidance are limited, and the high irritation index relative to iodine-containing dips is the primary reason for restricted commercial adoption.
In closed poultry and pig units, chloramine-T soluble powder or granules are introduced into the drinking water distribution system as a 1% w/v stock solution. The stock solution is prepared by dissolving 1.0 kg of API in 100 L of water in a high-density polyethylene tank at 20–25°C; the mixer is a 316L stainless steel impeller running for 10 min. The solution is injected into the header line after the pressure-reducing valve using a peristaltic pump calibrated to deliver 0.5–2.0 L/h against a line pressure of 2–4 bar. The final water residual for continuous application is maintained at 3–5 ppm total chlorine measured at the end of the most distal nipple drinker or cup. At pH 6.5–7.5, the equilibrium favors hypochlorous acid; above pH 8.5, hypochlorite ion predominates and the required contact time for bacterial reduction increases from 30 min to more than 60 min. A shock disinfection program uses 20–50 ppm total chlorine for 1–2 h in empty buildings after flock or batch removal. Before shock dosing, the lines are cleaned with a 1% citric acid pulse at pH 3 for 30 min to remove carbonate scale, then rinsed with raw water until the pH returns to 7.0. Chloramine-T alone does not remove established biofilm; mechanical pigging and high-pressure air scouring are required before chemical sanitation. DPD colorimetric measurement at 530 nm following ISO 7393-2 is used because iodometric titration is susceptible to interference from organic matter in the line. Pumps with silicone tubing are replaced every 90 days because oxidizer attack causes hardening and flow drift. Water consumption is monitored daily; unexplained reductions of more than 10% during continuous treatment may indicate palatability effects at residual levels above 5 ppm. Standards for drinking water disinfectants in livestock are jurisdiction-specific; within the EU, chloramine-T as a product for drinking water disinfection falls under BPR 528/2012 product-type PT5 where authorized. The powder should not be mixed with concentrated acids, ammonium salts, or sulfite-based dechlorinators in the stock tank. Published data for production-scale broiler weight gain under 5 ppm continuous administration are limited; field programs rely on integrator water sanitation protocols.
Table 1. Application concentration matrix
| Application | Working concentration | Contact time | Analytical method | Operational boundary |
|---|---|---|---|---|
| Large-animal wound irrigation | 0.4% w/v | 3–5 min | ISO 7393-3 iodometric titration | Use within 24 h at 20–25°C |
| Recirculating aquaculture bath | 7–15 mg/L | 60 min | ISO 7393-2 DPD at 530 nm | Bypass UV and carbon; water temperature ≤ 20°C |
| Poultry/pig drinking water continuous | 3–5 ppm total chlorine | 30 min | ISO 7393-2 DPD | pH 6.5–7.5; efficacy drops above pH 8.5 |
| Dairy footbath | 1.0–2.0% w/v | 10–15 s per cow passage | DPD photometry | Replace after 150–200 cow passes |
| Maternity pen surface sanitation | 1.0–2.0% w/v | ≥ 15 min | ATP swab after treatment | Extend to 30 min at 5°C |
Effervescent tablets for pond treatment are formulated by dry granulation rather than aqueous wet granulation because chloramine-T reacts with citric acid in the presence of moisture. A representative starting formula contains 45% w/w chloramine-T trihydrate, 25% w/w sodium bicarbonate, 15% w/w anhydrous citric acid, 5% w/w sodium carbonate, 4% w/w polyvinylpyrrolidone K30, and 1% w/w magnesium stearate, with a target tablet weight of 10 g. The API is first compacted with sodium bicarbonate and half of the PVP at a roller compactor pressure of 50–70 kN; citric acid is separately granulated with the remaining PVP. The two granulate fractions are blended for 8 min at 12 rpm in a bin blender under relative humidity below 20% and at 20–25°C. Compression is performed on a 32-station rotary tablet press with chromium-plated tooling; main compression force is held at 18–25 kN, pre-compression at 5–8 kN, and turret speed at 20–30 rpm. Tablet hardness is maintained at 80–120 N, friability below 0.5% according to USP <1216>, and disintegration time below 3 min in 1 L of water at 25°C according to USP <701>. When a 5 g chloramine-T tablet is placed in a 500 L warmwater pond, the theoretical dose is 10 mg/L; effervescence provides localized mixing but a submersible pump is still required for uniform distribution in ponds deeper than 1 m. The tablet formulation is intended for prescription use in certain warmwater aquaculture species for external bacterial disease; published efficacy data for channel catfish and tilapia under field conditions are limited, and the dose must be adjusted for organic load in earthen ponds. Water hardness above 300 mg/L as CaCO₃ slows disintegration slightly because carbonate scale can form on the tablet surface, but the disintegrant system is less sensitive than simple powder broadcast. The tablets are packed in aluminum-foil blister strips with desiccant because humidity above 30% causes premature effervescence and active chlorine loss. A 12-month stability program at 25°C and 60% relative humidity with lot testing at 3, 6, 9, and 12 months is used to verify active chlorine retention of at least 95% of label claim. Tablets are not suitable for use in recirculating systems with biofilters unless the filter is bypassed and the residual is allowed to decay below 0.1 mg/L before reconnection.
At 1.0–2.0% w/v, chloramine-T is used as a footbath disinfectant in dairy housing where copper and zinc runoff restrictions create a need for a non-heavy-metal option. The bath is prepared by dispersing 1.0 kg of API into 100 L of soft water in a polypropylene footbath; the pH is adjusted to 9.0 with sodium carbonate. Each cow is walked through the bath at normal alley speed, providing 10–15 s of contact per foot. The working capacity is approximately 150–200 cow passes per 100 L bath; after this threshold, total chlorine measured by DPD photometry falls below 0.5 g/L, and replacement is required. Concrete and rubber mat surfaces show no visible staining in short-term use, unlike copper sulfate or iodine formulations. The solution does not release formaldehyde vapor, and ammonia emissions are low above pH 8.0. Peer-reviewed controlled data for the control of digital dermatitis lesions are limited; the primary use is environmental hygiene and reduction of organic contamination in footbath stations. Spent solution contains p-toluenesulfonamide and residual chlorine, must be neutralized with sodium thiosulfate at 0.5 g per 100 L before land application, and must not be discharged directly to surface water. At ambient temperatures below 5°C, the antimicrobial reaction rate declines; the contact time per pass is insufficient for sporicidal or fungal endpoints. For prefilled footbath tanks with 200 L capacity, an in-line mixing venturi is used to avoid manual dust exposure. Operators wear nitrile gloves and eye protection because the dry powder is a respiratory and skin irritant. Efficacy testing under EN 1656:2019 at 1.0% w/v and 15 min in dirty conditions has not been published; therefore, on-farm validation is required. There is no published mastitis or digital dermatitis treatment claim under current veterinary medicines regulations in the EU or US for this use pattern, and the bath is confined to operational hygiene protocols.
Table 2. Compliance and in-use parameter matrix
| Parameter | Method | Acceptance range | Standard or regulation |
|---|---|---|---|
| Active chlorine in API trihydrate | Iodometric titration | 23–26% w/w | ISO 7393-3 |
| Loss on drying | Vacuum oven at 60°C | 9–11% w/w | Supplier specification |
| Tablet friability | Rotating drum | < 0.5% | USP <1216> |
| Tablet disintegration | 1 L water at 25°C | < 3 min | USP <701> |
| Dechlorination endpoint | DPD photometry | < 0.1 ppm | ISO 7393-2 |
| Dermal irritation | Repeated exposure 3× daily for 5 days | Erythema score > 2 at 0.5% | OECD 404 |
| Post-disinfection surface | ATP bioluminescence swab | < 10 RLU per 100 cm² | Internal validation standard |
Calving pen programs use a 0.5% w/v chloramine-T solution for navel antisepsis when calves arrive at the hutch within 2 h of birth. The solution is mixed in a 20 L high-density polyethylene carboy at 20–25°C; a fresh dose is prepared every 8 h because active chlorine declines and organic contamination accumulates. Each calf receives 500 mL of solution through a low-pressure spray pump directed at the umbilical stump and surrounding ventral abdomen; contact time is 30 s, after which the area is allowed to air dry. For maternity pen surface sanitation, a 1.0–2.0% w/v solution is applied at 300 mL/m² using a foaming lance connected to a diaphragm pump at 3–5 bar. The pen surface must be pre-cleaned with a neutral detergent and rinsed before chloramine-T application. The treated surface is held wet for at least 15 min at temperatures above 10°C. At 5°C, the required contact time is extended to 30 min because hypochlorous acid penetration into biofilms is slower. Efficacy data for bactericidal reduction under EN 14349:2012 under dirty conditions are limited; therefore, dairy managers validate the program with ATP swab readings below 10 RLU per 100 cm² after treatment. The 1% solution is moderately alkaline and can leave white sodium sulfate residues on concrete if hard water is used; softened water reduces this effect. Used solution is collected and neutralized with sodium thiosulfate at 0.5 g per 100 L before removal to the manure pit. Metal buckets and galvanized fittings are incompatible; only polyethylene, polypropylene, and EPDM seals are used. Published data for calf navel infection reduction under chloramine-T field protocols are limited, and treatment is adjunctive to colostrum management and clean bedding rather than a standalone intervention.
Between swine groups, a chloramine-T premix powder is introduced at 50 ppm total chlorine into the empty drinking water distribution system for a 2 h stand. The premix is first diluted to a 1% w/v stock solution in a 200 L high-density polyethylene tank using softened water at 20–25°C. A diaphragm metering pump calibrated at 1.0 L/min injects the stock into the pipeline against a line pressure of 3 bar. Water is circulated through the unused lines for 30 min until total chlorine measured at the most distal nipple riser is not less than 20 ppm. The line is then valved off and held for 2 h at 20°C. At the end of the contact period, total chlorine is determined by DPD photometry using ISO 7393-2; acceptance is a residual of at least 10 ppm at the distal point. At water temperatures below 10°C, the hold time is extended to 4 h because the disinfection kinetics of hypochlorous acid slow by approximately 2-fold per 10°C decrease. A bypass flow cell with an ORP electrode provides continuous verification; readings below 650 mV versus Ag/AgCl require re-chlorination. Test strips are not acceptable for batch release because they cannot distinguish combined chlorine and lack traceability. After the hold period, the oxidant is drained to a neutralization tank and dosed with sodium thiosulfate at a stoichiometric ratio of 0.5 g per 100 L per mg/L residual until the DPD reading is below 0.1 ppm. The neutralized water is then discharged to the manure storage system. The procedure is validated with aerobic plate counts on line swabs before and after sanitation; a reduction from more than 100 CFU/cm² to less than 10 CFU/cm² is used as an internal target, although published data for chloramine-T at this concentration in swine biofilms are limited. Polypropylene, high-density polyethylene, and PVC are compatible; natural rubber gaskets and cast iron fittings must be replaced with EPDM and 316L stainless steel before chlorine-based sanitation. The premix should not be mixed with acid-based line cleaners in the same tank unless the tank is rinsed thoroughly because concentrated acid releases chlorine gas.
Competitive Chloramine-T Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@ascent-petrochem.com.
We will respond to you as soon as possible.
Tel: +8618963613625
Email: sales10@ascent-petrochem.com
Flexible payment, competitive price, premium service - Inquire now!
Chloramine-T Veterinary Grade API, identified as N-chloro-p-toluenesulfonamide sodium salt trihydrate, CAS 7080-50-4, is supplied as a white to pale-yellow crystalline powder with an available chlorine fraction of 24.0–26.5% w/w. The anhydrous form carries CAS 127-65-1 and the molecular formula C7H7ClNO2S·Na, while the trihydrate has a formula weight of 281.69 g/mol. In this molecule chlorine is covalently bound to the sulfonamide nitrogen, which distinguishes it from sodium hypochlorite and other free-halogen donors. The veterinary-grade API is distributed in two principal model grades: a granulation grade with a laser-diffraction particle-size distribution of D90 ≤ 150 µm for dry-mix solid dosage forms, and a micronized grade with D90 ≤ 45 µm for liquid dispersion and filtration-critical preparations. Exact manufacturer model codes differ across supply chains; no harmonized pharmacopoeial typology exists, and published data for this specific configuration is limited. Release specifications must therefore be verified against the current certificate of analysis for each lot.
| Attribute | Method | Typical specification |
|---|---|---|
| Appearance | Visual inspection | White to pale-yellow crystalline powder |
| Assay on dried basis | Iodometric titration | 98.0–103.0% C7H7ClNO2S·Na·3H2O |
| Available chlorine | Iodometric titration after acidification | 24.0–26.5% w/w |
| Loss on drying | Vacuum drying at 60 °C for 4 h | ≤ 2.0% |
| pH of 2% w/v solution | Potentiometric | 8.0–10.0 |
| Water-insoluble matter | Gravimetric filtration | ≤ 0.1% |
| Particle size, granulation grade | Laser diffraction ISO 13320:2020 | D90 ≤ 150 µm |
| Particle size, micronized grade | Laser diffraction ISO 13320:2020 | D90 ≤ 45 µm |
| Bulk density | USP <616> method II | 0.75–0.95 g/cm³ |
| Tapped density | USP <616> method II | 0.90–1.10 g/cm³ |
Incoming quarantine should include identity confirmation by infrared or Raman spectroscopy against a qualified reference standard, followed by iodometric assay. Because the trihydrate can lose water of crystallization under dry heat, the loss on drying value must be obtained before calculating the assay on dried basis. The available chlorine result should be interpreted alongside the assay; a low available chlorine value with an acceptable assay may indicate the presence of free sulfonamide or non-halogenated degradation products, requiring further investigation by HPLC. Batch-to-batch variation in particle size from different vendors can shift the direct-compression Carr index by 3–5 units, so a target D90 range rather than a single point is specified.
Solid-dose manufacturing with Chloramine-T is governed less by chemical reactivity than by the particle-size distribution, bulk density, and segregation tendency of the trihydrate crystals. When the granulation grade is evaluated by USP <616> method II, bulk density values falling between 0.75 g/cm³ and 0.95 g/cm³ and tapped density values between 0.90 g/cm³ and 1.10 g/cm³ produce a Carr index frequently in the tableting-acceptable range of 17–23. Direct compression blends containing more than 5.0% w/w API generally require a glidant such as colloidal silicon dioxide at 0.25–0.50% w/w and a lubricant such as magnesium stearate at 0.50–1.0% w/w to maintain die-fill consistency and avoid punch sticking. Low-dose tablet blends at 0.5–2.0% w/w active ingredient should be prepared by geometric dilution; finished-product content uniformity is then assessed by USP <905> or Ph. Eur. 2.9.40. The micronized grade is not recommended as the sole API source for direct compression because its high surface area can increase electrostatic adhesion to stainless-steel tooling and reduce flow.
On a rotary tablet press with standard concave tooling, granulation-grade Chloramine-T blends are compressed at 5–15 kN; tablet hardness is maintained at 40–80 N and friability is kept below 1.0% when tested according to USP <1216>. Higher compression force does not improve disintegration; instead, it can reduce solution release from disinfectant tablets by densifying the matrix. A disintegrant such as crospovidone at 2.0–5.0% w/w is added when the tablet must dissolve within 5 minutes in 30–35 °C water. Dissolution testing in water at 37 °C with paddle speed 50 rpm is used only as process control; final disinfectant efficacy is not inferred from dissolution time alone.
For hard gelatin and HPMC capsules, the granulation-grade API can be dry-filled when the loss on drying is ≤ 2.0% and the filling suite is maintained below 60% RH. Above 70% RH, surface dampening may initiate gradual chlorine loss and slight yellowing of the powder bed. Pre-drying of the API at 40 °C for 2–4 h is specified when warehouse RH exceeds 60% before weighing. In wet-granulation processes, aqueous granulation should be dried at 40–50 °C under vacuum, not exceeding 600 mmHg, because exposure above 60 °C accelerates liberation of chlorine gas. Binder selection should exclude reducing sugars, sorbitol, and other polyols that consume available chlorine; pregelatinized starch or hypromellose at 2.0–5.0% w/w is generally compatible in short processing windows. Granules intended for subsequent solution reconstitution should be sieved through a 1000 µm screen and blended with an effervescent or pH-buffering system to maintain the aqueous pH between 8.0 and 10.0 upon dissolution.
Powder and granule presentations are used primarily to prepare extemporaneous disinfectant solutions for equipment, housing surfaces, and drinking-water lines. A dry premix is typically prepared by blending the granulation-grade API with anhydrous sodium sulfate or sodium chloride carrier to a final in-use concentration calculated to yield 250–2500 mg/L available chlorine; the exact target depends on soil load, contact time, and the bacterial reduction claim validated under EN 1656:2019. Dry blending should use a low-shear tumble blender rather than a high-shear granulator, because high-shear mixing above 1000 rpm can raise the powder temperature by 5–8 °C through friction and accelerate chlorine loss. The premix should be stored in sealed polyethylene-lined fiber drums at 20–25 °C and ≤ 60% RH; under these conditions a retest period of 24 months is commonly assigned. Published data for this specific packaging configuration is limited.
| Dosage form | Typical processing route | Critical control parameter | Specification or standard |
|---|---|---|---|
| Tablets | Direct compression or dry granulation | Blend uniformity, compression force, friability | USP <905>, USP <1216> |
| Capsules | Dry fill | Humidity, loss on drying | ≤ 60% RH, ≤ 2.0% |
| Powders or granules | Low-shear dry blending | Blend RSD | ≤ 5.0% |
| Premix | Carrier blending | Available chlorine after mixing | 250–2500 mg/L at point of use |
| Solutions | Dissolution in demineralized water | pH, container, use window | pH 8.0–10.0, use within 24 h |
| Injections, where permitted | Micronized grade plus aseptic filtration | Filter compatibility, endotoxin | 0.22 µm PES, <0.25 EU/mL |
In aqueous formulations, pH and photolytic degradation control the available-chlorine half-life. A freshly prepared 0.1% w/v solution of the trihydrate exhibits pH between 8.0 and 10.0; below pH 6.0 the equilibrium shifts toward hypochlorous acid, increasing mucosal irritation potential and accelerating chlorine loss. Dissolution in demineralized water at 30–35 °C under low-shear stirring is typically complete within 5 minutes; high-vortex mixing above 1000 rpm is unnecessary and may entrain carbon dioxide, which lowers pH. Solutions intended for topical irrigation, wound antisepsis, or equipment disinfection should be prepared no more than 24 hours before use and stored in amber HDPE or Type III glass at 20–25 °C; under these conditions available chlorine loss is typically held below 10% over 24 hours. Containers made from aluminum, brass, or copper must be avoided because metal ions catalyze chloramine decomposition. Stainless steel 316L is acceptable for short contact times at pH above 8.0, but prolonged storage in stainless steel is not recommended.
Injectable preparations present a different sterility and filtration burden. Regulatory status varies by jurisdiction; Chloramine-T is not a universal injectable active substance and is used only where site-specific veterinary protocols or approved compounding frameworks permit. The micronized grade with D90 ≤ 45 µm is preferred for liquid processing because it reduces the filtration load when a suspension or solution is passed through a 5.0 µm pre-filter and then a 0.22 µm polyethersulfone membrane. Terminal moist-heat sterilization at 121 °C for 15 minutes is generally unsuitable because the sulfonamide-chlorine bond is heat-labile in aqueous solution; aseptic filtration is the usual route for sterile solutions. The formula should be prepared with water for injection meeting Ph. Eur. 2.6.14 bacterial endotoxin limits of <0.25 EU/mL. The API itself is not sterile and must be sterilized downstream; bulk powder sterilization by gamma irradiation at 25 kGy is not universally validated for this product and may generate free radicals that reduce available chlorine.
Chloramine-T differs from inorganic hypochlorite salts in the chemical form of the active chlorine. Sodium hypochlorite at 10–14% w/w available chlorine has a pH of 11.0–13.0 and releases chlorine rapidly; Chloramine-T in aqueous solution maintains a buffered pH of 8.0–10.0 and delivers chlorine through hydrolysis of the N-chloro bond. This slower release reduces volatile chlorine generation during mixing and lowers the corrosion rate on 316L stainless steel in short-contact applications, but it also means that contact times for equivalent log10 reduction may be longer. Compared with Chloramine-B, the p-toluenesulfonyl substituent on Chloramine-T increases molar mass and modifies solubility; the difference affects residue retention on concrete and plastic surfaces and may require different rinsing volumes. Compared with povidone-iodine 10% solution, Chloramine-T introduces no iodine and therefore avoids iodine stains on surfaces and equipment; however, its spectrum against bacterial spores and certain non-enveloped viruses is less thoroughly documented in veterinary field trials, and efficacy claims must be validated under site-specific soiling conditions rather than inferred from reference products.
If reconstituted solutions are mixed with acid detergents or ammonia-based compounds, toxic gas formation can occur; dedicated vessels and separate disposal streams are required. In drinking-water disinfection for poultry housing, the target free residual after the required contact time is commonly verified by DPD colorimetric or amperometric methods and expressed as milligrams per litre of free chlorine rather than total chlorine because combined chloramines may be present in nitrogenous water. Site-specific efficacy validation under EN 1656:2019 or an equivalent quantitative suspension test is required for the intended veterinary hygiene claim. Any lot showing an available chlorine result below 24.0% w/w should not be reworked without confirmatory assay and degradation profiling, because loss of active chlorine may signal decomposition that alters dissolution behavior and antimicrobial performance.